Iradimed (IRMD) Operating Income Growth (3y) (2016 - 2026)
Iradimed (IRMD) Operating Income Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 13.06% |
| 10 | Iradimed | 1.12 Bn | 1.06 Bn | 15.16 Mn | 8.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.79% |
| Mar 31, 2026 | 21.78% |
| Dec 31, 2025 | 18.59% |
| Sep 30, 2025 | 18.26% |
| Jun 30, 2025 | 17.67% |
| Mar 31, 2025 | 20.89% |
| Dec 31, 2024 | 23.10% |
| Sep 30, 2024 | 23.32% |
| Jun 30, 2024 | 45.04% |
| Mar 31, 2024 | 38.77% |
| Dec 31, 2023 | 99.38% |
| Sep 30, 2023 | 95.96% |
| Jun 30, 2023 | 54.59% |
| Mar 31, 2023 | 75.82% |
| Dec 31, 2022 | 23.86% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | 20.59% |
| Mar 31, 2022 | 26.64% |
| Dec 31, 2021 | 20.15% |
| Sep 30, 2021 | 28.70% |